tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market
DNTH
Dianthus Therapeutics
RESEARCH TOOLSreports
Want to see DNTH full AI Analyst Report?

Dianthus Therapeutics (DNTH) Income Statement

434 Followers

Dianthus Therapeutics Income Statement

Last quarter (Q4 2025), Dianthus Therapeutics's total revenue was $284.00K, a decrease of -78.58% from the same quarter last year. In Q4, Dianthus Therapeutics's net income was $97.91M. See Dianthus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.04M$ 6.24M$ 2.83M$ 6.42M$ 1.48M
Gross Profit
$ 2.04M$ 6.24M$ 2.83M$ 6.42M$ 1.48M
Operating Expenses
$ 179.97M$ 108.10M$ 51.00M$ 36.12M$ 14.56M
Depreciation and Amortization
$ 0.00$ 412.00K$ 355.00K$ 147.00K$ 0.00
EBITDA
$ -177.93M$ -101.45M$ -47.82M$ -29.56M$ -13.09M
Operating Income
$ -177.93M$ -101.86M$ -48.17M$ -29.70M$ -13.09M
Other Income/Expenses
$ 15.60M$ 16.89M$ 4.62M$ 1.23M$ -23.00K
Pretax Income
$ -162.34M$ -84.97M$ -43.55M$ -28.48M$ -13.11M
Net Income
$ -162.34M$ -84.97M$ -43.55M$ -28.48M$ -13.11M
Per Share Metrics
Basic EPS
$ -4.20$ -2.55$ -8.45$ -7.60$ -3.82
Diluted EPS
$ -4.20$ -2.55$ -8.45$ -7.60$ -3.82
Weighted Average Shares Outstanding
 37.79M 33.31M 5.15M 3.75M 3.43M
Weighted Average Shares Outstanding (Diluted)
 37.79M 33.31M 5.15M 3.75M 3.43M
Currency in USD

Dianthus Therapeutics Earnings and Revenue History